Charles River Laboratories International Inc. | |
Stock Exchange | New York Stock Exchange |
EPS |
$4.65 |
Market Cap |
$6.94 B |
Shares Outstanding |
48.75 M |
Public Float |
47.32 M |
Address |
251 Ballardvale Street Wilmington Massachusetts 01887 United States |
Employees | - |
Website | http://www.criver.com |
Updated | 07/08/2019 |
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following business segments: Research Models & Services, Discovery & Safety Assessment, and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. |